Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Weinstein

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Vox Sanguinis|February 27, 2004
Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United StatesD A Marshall, S H Kleinman, J B Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2001
Preevaluation of clinical trial data: the case of preemptive cytomegalovirus therapy in patients with human immunodeficiency virusA D Paltiel, S J Goldie, E Losina, et al.
Journal of General Internal Medicine|October 1, 1994
Using health-related quality-of-life information: clinical encounters, clinical trials, and health policyJ Tsevat, J C Weeks, E Guadagnoli, et al.
JAMA|February 19, 1997
The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatmentM G Hunink, L Goldman, A N Tosteson, et al.
Annals of Internal Medicine|March 20, 2001
Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectivenessM C Weinstein, S J Goldie, E Losina, et al.
Circulation|May 1, 1992
Cost and health implications of cholesterol loweringL Goldman, D J Gordon, B M Rifkind, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 5, 1998
A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infectionA D Paltiel, J A Scharfstein, G R Seage, et al.
JAMA|August 31, 2001
Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyondJ A Tice, E Ross, P G Coxson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 14, 2001
Modeling for health care and other policy decisions: uses, roles, and validityM C Weinstein, E L Toy, E A Sandberg, et al.
JAMA|December 6, 2000
Health and economic benefits of increased beta-blocker use following myocardial infarctionK A Phillips, M G Shlipak, P Coxson, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Vox Sanguinis|February 27, 2004
Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United StatesD A Marshall, S H Kleinman, J B Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2001
Preevaluation of clinical trial data: the case of preemptive cytomegalovirus therapy in patients with human immunodeficiency virusA D Paltiel, S J Goldie, E Losina, et al.
Journal of General Internal Medicine|October 1, 1994
Using health-related quality-of-life information: clinical encounters, clinical trials, and health policyJ Tsevat, J C Weeks, E Guadagnoli, et al.
JAMA|February 19, 1997
The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatmentM G Hunink, L Goldman, A N Tosteson, et al.
Annals of Internal Medicine|March 20, 2001
Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectivenessM C Weinstein, S J Goldie, E Losina, et al.
Circulation|May 1, 1992
Cost and health implications of cholesterol loweringL Goldman, D J Gordon, B M Rifkind, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 5, 1998
A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infectionA D Paltiel, J A Scharfstein, G R Seage, et al.
JAMA|August 31, 2001
Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyondJ A Tice, E Ross, P G Coxson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 14, 2001
Modeling for health care and other policy decisions: uses, roles, and validityM C Weinstein, E L Toy, E A Sandberg, et al.
JAMA|December 6, 2000
Health and economic benefits of increased beta-blocker use following myocardial infarctionK A Phillips, M G Shlipak, P Coxson, et al.
Pageof 16